Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 4
2015 2
2016 3
2017 6
2018 8
2019 3
2020 5
2021 2
2022 2
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Phosphodiesterase inhibitors say NO to Alzheimer's disease.
Nabavi SM, Talarek S, Listos J, Nabavi SF, Devi KP, Roberto de Oliveira M, Tewari D, Argüelles S, Mehrzadi S, Hosseinzadeh A, D'onofrio G, Orhan IE, Sureda A, Xu S, Momtaz S, Farzaei MH. Nabavi SM, et al. Food Chem Toxicol. 2019 Dec;134:110822. doi: 10.1016/j.fct.2019.110822. Epub 2019 Sep 16. Food Chem Toxicol. 2019. PMID: 31536753 Review.
PDE inhibitors (PDEIs) have been attractive therapeutic targets due to their involvement in diverse medical conditions, e.g. cardiovascular diseases, autoimmune diseases, Alzheimer's disease (AD), etc. Among them; AD with a complex pathology is a progressive neurodegenerat …
PDE inhibitors (PDEIs) have been attractive therapeutic targets due to their involvement in diverse medical conditions, e.g. cardiovascular …
Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.
Bagherifard A, Hosseinzadeh A, Koosha F, Sheibani M, Karimi-Behnagh A, Reiter RJ, Mehrzadi S. Bagherifard A, et al. Osteoporos Int. 2023 Oct;34(10):1677-1701. doi: 10.1007/s00198-023-06836-1. Epub 2023 Jul 2. Osteoporos Int. 2023. PMID: 37393580 Review.
The aging of world population has encouraged scientists to further explore the most effective preventive modalities and therapeutic strategies to overcome and reduce the high cost of bone disorders. Herein, we review the current evidence of melatonin's therapeutic effects …
The aging of world population has encouraged scientists to further explore the most effective preventive modalities and therapeutic strategi …
Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases.
Hosseinzadeh A, Alinaghian N, Sheibani M, Seirafianpour F, Naeini AJ, Mehrzadi S. Hosseinzadeh A, et al. Life Sci. 2024 May 1;344:122557. doi: 10.1016/j.lfs.2024.122557. Epub 2024 Mar 11. Life Sci. 2024. PMID: 38479596 Review.
This review consolidates the accumulating evidence on melatonin's multifaceted protective effects in different pathological contexts. ...It inhibits adhesion molecules' production, and potentially mitigates leukocyte adherence and inflammatory responses. Melatonin's …
This review consolidates the accumulating evidence on melatonin's multifaceted protective effects in different pathological contexts. …
Molecular Aspects of Melatonin Treatment in Tinnitus: A Review.
Hosseinzadeh A, Kamrava SK, Moore BCJ, Reiter RJ, Ghaznavi H, Kamali M, Mehrzadi S. Hosseinzadeh A, et al. Curr Drug Targets. 2019;20(11):1112-1128. doi: 10.2174/1389450120666190319162147. Curr Drug Targets. 2019. PMID: 30892162 Review.
The expression of neural plasticity related to excessive glutamatergic neurotransmission leads to generation of abnormal sound in one's ears or head. Furthermore, hyperactivation and over-expression of NMDA receptors in response to excessive release of glutamate contribute …
The expression of neural plasticity related to excessive glutamatergic neurotransmission leads to generation of abnormal sound in one's …
Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis.
Hosseinzadeh A, Pourhanifeh MH, Amiri S, Sheibani M, Irilouzadian R, Reiter RJ, Mehrzadi S. Hosseinzadeh A, et al. Pharmacol Rep. 2024 Feb;76(1):25-50. doi: 10.1007/s43440-023-00554-5. Epub 2023 Nov 23. Pharmacol Rep. 2024. PMID: 37995089 Review.
While it is often effective in treating sleep disorders, melatonin's anti-inflammatory and antioxidant properties also make it a promising molecule for treating other disorders such as organ fibrosis. ...
While it is often effective in treating sleep disorders, melatonin's anti-inflammatory and antioxidant properties also make it a prom …
37 results